These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 16978201)

  • 1. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
    Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
    Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathologic characteristics and histogenesis of mucinous tumor of peritoneum].
    Zhang H; Sun Y; Huang X; Jia L; Bai Y; Cao D
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):163-8. PubMed ID: 24842014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei Arising from Urachus.
    Liu Y; Ishibashi H; Hirano M; Takeshita K; Mizumoto A; Ichinose M; Nishino E; Kashu I; Yamamoto Y; Sugarbaker PH; Yonemura Y
    Ann Surg Oncol; 2015 Aug; 22(8):2799-805. PubMed ID: 25572681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian mucinous tumour arising in mature cystic teratoma and associated with pseudomyxoma peritonei: report of two cases and comparison with ovarian involvement by low-grade appendiceal mucinous tumour.
    Stewart CJ; Tsukamoto T; Cooke B; Leung YC; Hammond IG
    Pathology; 2006 Dec; 38(6):534-8. PubMed ID: 17393980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
    Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.
    Baratti D; Kusamura S; Milione M; Pietrantonio F; Caporale M; Guaglio M; Deraco M
    Ann Surg Oncol; 2016 Dec; 23(13):4222-4230. PubMed ID: 27352203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological origin of pseudomyxoma peritonei in Chinese women: clinicopathology and immunohistochemistry.
    Guo AT; Song X; Wei LX; Zhao P
    World J Gastroenterol; 2011 Aug; 17(30):3531-7. PubMed ID: 21941421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronous Ovarian and Appendiceal Mucinous Neoplasms in the Absence of Pseudomyxoma Peritonei.
    Gui X; Escobar J; Lee CH; Duggan MA; Köbel M
    Int J Gynecol Cancer; 2017 Feb; 27(2):214-222. PubMed ID: 27870702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC2 is a molecular marker for pseudomyxoma peritonei.
    O'Connell JT; Hacker CM; Barsky SH
    Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific cadherin phenotype may characterise the disseminating yet non-metastatic behaviour of pseudomyxoma peritonei.
    Bibi R; Pranesh N; Saunders MP; Wilson MS; O'dwyer ST; Stern PL; Renehan AG
    Br J Cancer; 2006 Nov; 95(9):1258-64. PubMed ID: 17031402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
    Ronnett BM; Zahn CM; Kurman RJ; Kass ME; Sugarbaker PH; Shmookler BM
    Am J Surg Pathol; 1995 Dec; 19(12):1390-408. PubMed ID: 7503361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.
    Ferreira CR; Carvalho JP; Soares FA; Siqueira SA; Carvalho FM
    Int J Gynecol Cancer; 2008; 18(1):59-65. PubMed ID: 17511804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian mucinous tumor arising in mature cystic teratoma associated with pseudomyxoma peritonei: a case with possible respiratory epithelial differentiation.
    Stewart CJ; Junckerstorff R; Tsukamoto T
    Int J Gynecol Pathol; 2008 Jan; 27(1):41-3. PubMed ID: 18156973
    [No Abstract]   [Full Text] [Related]  

  • 16. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.
    Carr NJ; Cecil TD; Mohamed F; Sobin LH; Sugarbaker PH; González-Moreno S; Taflampas P; Chapman S; Moran BJ;
    Am J Surg Pathol; 2016 Jan; 40(1):14-26. PubMed ID: 26492181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomyxoma peritonei--a heterogenous disease.
    Shen DH; Ng TY; Khoo US; Xue WC; Cheung AN
    Int J Gynaecol Obstet; 1998 Aug; 62(2):173-82. PubMed ID: 9749889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary ovarian carcinoid tumors may express CDX-2: a potential pitfall in distinction from metastatic intestinal carcinoid tumors involving the ovary.
    Rabban JT; Lerwill MF; McCluggage WG; Grenert JP; Zaloudek CJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):41-8. PubMed ID: 19047909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma.
    Kennedy MT; Jordan RC; Berean KW; Perez-Ordoñez B
    J Clin Pathol; 2004 Sep; 57(9):932-7. PubMed ID: 15333652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients.
    Jackson SL; Fleming RA; Loggie BW; Geisinger KR
    Mod Pathol; 2001 Jul; 14(7):664-71. PubMed ID: 11454998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.